Suppurative tuboovarial of derivation (clinic, diagnostic, principles of therapy)
D. F. Kqstuchek
Journal of obstetrics and women's diseases ›› 1997, Vol. 46 ›› Issue (1) : 63 -68.
Suppurative tuboovarial of derivation (clinic, diagnostic, principles of therapy)
You can find the personal views of the author on etiology, pathogenesis, clinical features and principles of therapy pelvic inflammory deseases in the lecture. The autors views are based on the large own experience.
purulent tubo-ovarian formations / clinic, diagnostics, principles of therapy / etiology / pathogenesis / purulent inflammatory diseases of the uterine appendages
| [1] |
Айламазян Э. К. Антиоксиданты в комплексной терапии позднего токсикоза беременных и связанной с ним хронической гипоксии плода // Акуш. и гинекол.-1991.-№3 -С. 30-33. |
| [2] |
Айламазян Э.К., Тарасова М.А. Иммунологические методы прогнозирования и диагностики позднего токсикоза беременных //Акуш. и гинекол. —1986. -№6 -С.39-41. |
| [3] |
Зазерская И.Е. Определение функциональной и метаболической активности тромбоцитов при позднем токсикозе//Автореф. дис... к.м.н-Л., 1991. -С. 21. |
| [4] |
Петрищев Н.Н. Тромборезистентность сосудов. - СПб, "АНТ-М", 1994 -С. 130. |
| [5] |
Репина М.А., Конычева Е.А. Состояние гемостаза у беременных с гестозом // Актуальные вопросы службы крови и трансфузиологии. -СПб, 1995.-С. 157-159. |
| [6] |
Торопова Б.Г., Горностаев В.С., Данилов О. А., Нягулов Д.Ф. и др. Иммуноферментный анализ фактора Виллебранда с использованием моноклональных антител.// Лаб. дело. -1990. -№10- С. 52-55. |
| [7] |
Arbogast В. W., Leeper S.C., Merrick R.D. et al. Which plasma factors bringth about disturbance of endoteliaI function in preeclampsia ?// Lancet. —1994 - Vol. 343.-P.3400-341. |
| [8] |
Bowry S. K., Prentice C. R. M., Courtney J. M. A modification of the Wu and Hoak method for the determination of platelet aggregates and platelet adhesion // Thromb. Haemost. - 1985.—Vol. 53,№3-P. 381-385. |
| [9] |
Caron C., Goudeman J., Marey A., Beage D. et al. Are haemostatic and fibrinolytic parametres predictors of preeclampsia in pregnancy-associated hypertension? // Thromb. Haemost.- 1991 -Vol.66, № 4.-P.4KM14. |
| [10] |
Davis J. W., Shehon L, Eigen berg D.A., Hignite C.E. et al. Effects of tobacco and nontobacco cigarette smoking on endothelium and platelete // Clin. PharmacoL Ther.-1985.-Vol.37. -P. 529-533. |
| [11] |
De Jager C.A., Shephard E.G., Robson S.C., Jaskiewicz K. et al. Degradation of fibronectin in association with vascular endothelial disruption in preeclampsia //J. Lab. Clin. Med.-1995.-Vol. 125.-№4.-P. 522-530. |
| [12] |
Delacretaz E., de Quay N., Waeber B., Vial Y. et al. Differential nitric oxide synthese activity in human platelets during normal pregnancy and preeclampsia // Clin. Sci. Colch. — 1995.—Vol.88.—№ 6.-P. 607-610. |
| [13] |
Dulitzki M., Pauzner R., Langevitz P., Prаs M. et al. Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies // Obstet. Gynecol. —1996. — Vol. 87. -№ 3. -P. 380-383. |
| [14] |
Friedman S. A. Preeclampsia: a review of the role of prostaglandins // Obstet. Gynecol. -1988. - Vol. 71.-P. 122-137. |
| [15] |
Friedman S.A., Lubarsky S.L., Ahokas R.A., Nova A. Preeclampsia and related disorders. Clinical aspects and relevance of endothelin and nitric oxide //Clin. Perinatol. -1995.-Vol.22. - № 2. - P. 343-355. |
| [16] |
Foumier A., Fievet P., el Esper I., el Esper N. et al. Hypertension et grossesse. Diagnostic, physiopathologie et traitment // Schweiz. Med. Wochenschr.-1995-Vol.125-№ 47. -P. 2273-2298. |
| [17] |
Furuhashi N., Kimura H., Nagae H., Yajima A. Maternal plasma endothelin levels and fetal status in normal and preeclamptic pregnancies // Gynecol. Obstet. Invest.-1995.-Vol.39.-N. 2 — P. 88-92. |
| [18] |
Ghabour M.S., Eis A. L, Brockman D.E., Pollock J. S. et al. Immunohistochemical characterization of placental nitric oxide synthase expression in preeclampsia //Am. J. Оbstet. Gynecol.-1995.-Vol. 173. -№3.-P. 687-694. |
| [19] |
Gillis S., Shushan A., Elder A. Use of low molecular weight heparin for prophylaxis and treatment of thromboembolism in pregnancy // Int. J. Gynaecol. Obstet.-1992.- Vol.39.-№4.-P. 297-301. |
| [20] |
Greer I.A., Leask R., Hodson B.A, Daves J. et al. Endothelin, elastase and endothelial disfunction in preeclampsia // Lancet.-1991. -Vol. 337. -P.558. |
| [21] |
Hladovec J., Rossmann P. Circulating endothelial cells isolated together with platelets and the experimental modification of their count in rats // Thromb. Res.-1973 -Vol.3.-P. 663-674. |
| [22] |
Ignarro L.J. Physiological significansc of nitric oxide // Semin. Perinatal.-1991 .- Vol. 15. -P. 20-26. |
| [23] |
Melissari E., Parker C.J., Wilson N. V., Monte G. et al. Use of low molecular weight heparin in pregnancy //Thromb. Haemost.-1992.-Vol. 68. -№ 6.-P.652-656. |
| [24] |
Pinto A., Sorrentmo R., Sorrentino P. et al. Endothelial derived relaxing factor released by endothelial cells of human umbilical vessels and its impairment in pregnancy-induced hypertension //Am. J. Obstet. Gynecol.-1991. -Vol. 164.-P. 507-513. |
| [25] |
Sabry S., Mondon P., Levy M, Ferre F. et al. Endothelial modulation of vasoconstrictor responses to endothelin-l in human placental stem villi small arteries // Br. J. Pharmacol.-1995.-Vol.115.-№ 6-P. 1038-1042. |
| [26] |
Sarrel P.M., Lindsay D.C., Poole- Wilson P.A. et al. Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of preeclampsia // Lancet.-1990 -Vol. 336-P. 1030-1032. |
| [27] |
Sinzinger H., Virgolini I., Fitscha P., Rauscha F. et al. Stabilization of endothelial lining and decrease in circulating endothelial cells one mechanism underlying the clinical action of PGEl ? // Br. J. Clin. Pharmacol-1988. -Vol. 25. -P. 775-776. |
| [28] |
Tomobe Y., Miyauchi T., Saito A., Yanagisawa M. et al. Effects of endothelin on the renal artery from spontaneously hypertensive and Wistar Kyoto rats //Europ. J. PharmacoL.- 1988.-Vol. 152. -№ 3.-P. 373-374. |
| [29] |
Vinatier D., Prolongeau J.F., Dufour P., Tordjeman N. Physiopathologie de la preeclampsie: place de I'immunologie // J. Gynecol. Obstet. Biol. Reprod. Paris.-1995. -Vol. 24. -№ 4. -P. 387-399. |
| [30] |
Vince G.S., Starkey P.M., Austgulen R., Kwiatkowski D. Interleukin-6, tumor necrosis factor and soluble tumor necrosis factor receptors in women with preeclampsia // Br. Y. Obstet. Gynaecol.-1995.- Vol. 102. -№ I. -P. 20-25. |
Eсо-Vector
/
| 〈 |
|
〉 |